JP2010535722A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535722A5
JP2010535722A5 JP2010519351A JP2010519351A JP2010535722A5 JP 2010535722 A5 JP2010535722 A5 JP 2010535722A5 JP 2010519351 A JP2010519351 A JP 2010519351A JP 2010519351 A JP2010519351 A JP 2010519351A JP 2010535722 A5 JP2010535722 A5 JP 2010535722A5
Authority
JP
Japan
Prior art keywords
alkyl
branched
linear
cycloalkyl
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010519351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535722A (ja
Filing date
Publication date
Priority claimed from EP07114019A external-priority patent/EP2022783A1/en
Application filed filed Critical
Publication of JP2010535722A publication Critical patent/JP2010535722A/ja
Publication of JP2010535722A5 publication Critical patent/JP2010535722A5/ja
Ceased legal-status Critical Current

Links

JP2010519351A 2007-08-08 2008-07-17 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体 Ceased JP2010535722A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07114019A EP2022783A1 (en) 2007-08-08 2007-08-08 "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
PCT/EP2008/005843 WO2009018909A2 (en) 2007-08-08 2008-07-17 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013212664A Division JP5746298B2 (ja) 2007-08-08 2013-10-10 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体

Publications (2)

Publication Number Publication Date
JP2010535722A JP2010535722A (ja) 2010-11-25
JP2010535722A5 true JP2010535722A5 (cg-RX-API-DMAC10.html) 2011-08-25

Family

ID=38754730

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010519351A Ceased JP2010535722A (ja) 2007-08-08 2008-07-17 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体
JP2013212664A Active JP5746298B2 (ja) 2007-08-08 2013-10-10 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体
JP2015094698A Active JP6023846B2 (ja) 2007-08-08 2015-05-07 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013212664A Active JP5746298B2 (ja) 2007-08-08 2013-10-10 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体
JP2015094698A Active JP6023846B2 (ja) 2007-08-08 2015-05-07 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体

Country Status (37)

Country Link
US (7) US7923565B2 (cg-RX-API-DMAC10.html)
EP (3) EP2022783A1 (cg-RX-API-DMAC10.html)
JP (3) JP2010535722A (cg-RX-API-DMAC10.html)
KR (1) KR101200683B1 (cg-RX-API-DMAC10.html)
CN (1) CN101796028B (cg-RX-API-DMAC10.html)
AR (1) AR068057A1 (cg-RX-API-DMAC10.html)
AU (1) AU2008286027B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0814065B8 (cg-RX-API-DMAC10.html)
CA (1) CA2695580C (cg-RX-API-DMAC10.html)
CL (1) CL2008002330A1 (cg-RX-API-DMAC10.html)
CO (1) CO6290760A2 (cg-RX-API-DMAC10.html)
CY (2) CY1117324T1 (cg-RX-API-DMAC10.html)
DK (2) DK2947068T3 (cg-RX-API-DMAC10.html)
EA (1) EA017530B1 (cg-RX-API-DMAC10.html)
ES (2) ES2655816T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20125537B (cg-RX-API-DMAC10.html)
HR (2) HRP20160292T1 (cg-RX-API-DMAC10.html)
HU (2) HUE035557T2 (cg-RX-API-DMAC10.html)
IL (2) IL203712A (cg-RX-API-DMAC10.html)
JO (1) JO3181B1 (cg-RX-API-DMAC10.html)
LT (1) LT2947068T (cg-RX-API-DMAC10.html)
MA (1) MA31586B1 (cg-RX-API-DMAC10.html)
ME (1) ME00974B (cg-RX-API-DMAC10.html)
MX (1) MX2010001544A (cg-RX-API-DMAC10.html)
MY (1) MY152692A (cg-RX-API-DMAC10.html)
NO (1) NO2947068T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ583103A (cg-RX-API-DMAC10.html)
PE (1) PE20090698A1 (cg-RX-API-DMAC10.html)
PL (2) PL2947068T3 (cg-RX-API-DMAC10.html)
PT (2) PT2185515E (cg-RX-API-DMAC10.html)
RS (2) RS56765B1 (cg-RX-API-DMAC10.html)
SI (2) SI2185515T1 (cg-RX-API-DMAC10.html)
TN (1) TN2010000044A1 (cg-RX-API-DMAC10.html)
TW (1) TWI444366B (cg-RX-API-DMAC10.html)
UA (1) UA99622C2 (cg-RX-API-DMAC10.html)
WO (1) WO2009018909A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201000832B (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022783A1 (en) * 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
EP2216327A1 (en) * 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
HRP20180488T1 (hr) 2010-04-21 2018-07-13 Chiesi Farmaceutici S.P.A. Postupak priprave čestica sa smanjenim elektrostatičkim nabojem
CA2807406C (en) 2010-08-03 2018-12-11 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation comprising a phosphodiesterase inhibitor
SI2600830T1 (en) * 2010-08-03 2018-05-31 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising a phosphodiesterase inhibitor
ES2704688T3 (es) * 2010-09-30 2019-03-19 Chiesi Farm Spa Uso de estearato de magnesio en formulaciones de polvo seco para inhalación
EP2718267B1 (en) 2011-06-06 2016-08-10 Chiesi Farmaceutici S.p.A. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
EP2760838B1 (en) 2011-09-26 2017-05-10 Chiesi Farmaceutici S.p.A. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
CN103889972A (zh) * 2011-10-21 2014-06-25 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物
IN2014DN10239A (cg-RX-API-DMAC10.html) 2012-06-04 2015-08-07 Chiesi Farma Spa
HK1212988A1 (zh) 2012-12-05 2016-07-22 奇斯药制品公司 作为pde-4抑制剂的苯基乙基吡啶衍生物
AR093796A1 (es) * 2012-12-05 2015-06-24 Chiesi Farm Spa Derivados del alcohol 1-fenil-2-piridinil alquilico como inhibidores de la fosfodiesterasa
KR20150091061A (ko) 2012-12-05 2015-08-07 키에시 파르마슈티시 엣스. 피. 에이. Pde4-억제제로서 페닐에틸피리딘 유도체
WO2014086852A1 (en) 2012-12-05 2014-06-12 Chiesi Farmaceutici S.P.A. Phenylethylpyridine derivatives as pde4-inhibitors
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
JP6458957B2 (ja) 2013-10-22 2019-01-30 チエシ ファルマスティスィ エス.ピー.エー. Pde4阻害剤の製造方法
AR098621A1 (es) 2013-12-05 2016-06-01 Chiesi Farm Spa Derivados de heteroarilo
HK1225384A1 (zh) * 2013-12-05 2017-09-08 奇斯药制品公司 用於治疗呼吸病的二苯甲基衍生物
EP3152202B1 (en) * 2014-06-04 2018-11-28 Chiesi Farmaceutici S.p.A. 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as pde-4 inhibitors and muscarinic m3 receptor antagonists
EP3152203A1 (en) * 2014-06-04 2017-04-12 Chiesi Farmaceutici S.p.A. 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)- 2-carbonyloxy)ethyl)pyridine derivatives as pde-4 inhibitors
US9326976B2 (en) 2014-06-05 2016-05-03 Chiesi Farmaceutici S.P.A. Carbamate derivatives
US9763924B2 (en) * 2014-06-05 2017-09-19 Chiesi Farmaceutici S.P.A. Aminoester derivatives
TW201710254A (zh) * 2015-06-01 2017-03-16 吉斯藥品公司 胺基酯衍生物
MA51413A (fr) 2017-12-28 2021-04-28 Chiesi Farm Spa Utilisation de dérivés d'alcool alkylique de 1-phényl-2-pyridinyl pour le traitement de la fibrose kystique
EP3960457A4 (en) 2019-04-26 2022-05-04 Fuji Corporation PRINT PARAMETER ACQUISITION DEVICE AND PRINT PARAMETER ACQUISITION METHOD
US12247674B2 (en) * 2021-01-18 2025-03-11 Chad Heffernan Eclipse valve assembly
WO2023117985A1 (en) 2021-12-21 2023-06-29 Chiesi Farmaceutici S.P.A. Dry powder formulations filled in an inhaler with improved resistance to humidity
JP2025514863A (ja) 2022-04-27 2025-05-09 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Pde4阻害剤の新規結晶形態
WO2024027901A1 (en) 2022-08-02 2024-02-08 Chiesi Farmaceutici S.P.A. Predictive biomarker of clinical response to a pde4 inhibitor
CN119947705A (zh) 2022-09-22 2025-05-06 奇斯药制品公司 用于施用磷酸二酯酶-4抑制剂的胶囊吸入器
WO2024062006A1 (en) 2022-09-22 2024-03-28 Chiesi Farmaceutici S.P.A. Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor
EP4590273A1 (en) 2022-09-22 2025-07-30 Chiesi Farmaceutici S.p.A. Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124455A (en) 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5935978A (en) * 1991-01-28 1999-08-10 Rhone-Poulenc Rorer Limited Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
PL307265A1 (en) * 1992-07-28 1995-05-15 Rhone Poulenc Rorer Ltd Compounds containing a phenyl group bonded with aryl or heteroaryl group through their bonding aliphatic group or that containing heteroatom
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
ATE217611T1 (de) 1996-09-17 2002-06-15 Merck & Co Inc Verfahren zur herstellung von phosphodiesterase iv inhibitoren
EP1157007A1 (en) 1999-02-25 2001-11-28 Merck Frosst Canada Inc. Pde iv inhibiting compounds, compositions and methods of treatment
KR20050111759A (ko) 2003-03-12 2005-11-28 셀진 코포레이션 7-아미노-이소인돌릴 화합물 및 그의 제약학적 용도
US20060239927A1 (en) * 2003-03-31 2006-10-26 Kyowa Hakko Kogyo Co., Drug for airway administration
US7888381B2 (en) * 2005-06-14 2011-02-15 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
DE602007012105D1 (de) * 2006-07-14 2011-03-03 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
EP2022783A1 (en) 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
EP2070913A1 (en) 2007-12-14 2009-06-17 CHIESI FARMACEUTICI S.p.A. Ester derivatives as phosphodiesterase inhibitors
EP2110375A1 (en) 2008-04-14 2009-10-21 CHIESI FARMACEUTICI S.p.A. Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
EP2216327A1 (en) * 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
SI2600830T1 (en) 2010-08-03 2018-05-31 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising a phosphodiesterase inhibitor
CA2807406C (en) 2010-08-03 2018-12-11 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation comprising a phosphodiesterase inhibitor
EP2718267B1 (en) 2011-06-06 2016-08-10 Chiesi Farmaceutici S.p.A. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
EP2760838B1 (en) 2011-09-26 2017-05-10 Chiesi Farmaceutici S.p.A. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
CN103889972A (zh) 2011-10-21 2014-06-25 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物
IN2014DN10239A (cg-RX-API-DMAC10.html) 2012-06-04 2015-08-07 Chiesi Farma Spa

Similar Documents

Publication Publication Date Title
JP2010535722A5 (cg-RX-API-DMAC10.html)
ATE556058T1 (de) 1-(2h)-isochinolonderivat
JP2015535277A5 (cg-RX-API-DMAC10.html)
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
WO2005037781A3 (fr) Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
RU2017125025A (ru) Конденсированные кольцевые гетероарильные соединения и их применение в качестве ингибиторов trk
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2006521359A5 (cg-RX-API-DMAC10.html)
AR082519A1 (es) Fenilamidinas que tienen alta actividad fungicida, y su utilizacion
JP2014525420A5 (cg-RX-API-DMAC10.html)
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
JP2011046700A5 (cg-RX-API-DMAC10.html)
JP2007508359A5 (cg-RX-API-DMAC10.html)
SE0400284D0 (sv) Novel compounds
JP2014526533A5 (cg-RX-API-DMAC10.html)
NO20070445L (no) Pyrimidinderivater.
MX344276B (es) Compuesto de piperidina novedoso o sal del mismo.
WO2008096870A1 (ja) アザ架橋環化合物
EA201270359A1 (ru) Терапевтическое средство от расстройств настроения
JP2006508979A5 (cg-RX-API-DMAC10.html)
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
RU2019131147A (ru) Новые хиназолиноновые производные, ингибирующие pi3k, и содержащая их фармацевтическая композиция
NO20080033L (no) Kinolinderivater som NK3-antagonister
JP2016500653A5 (cg-RX-API-DMAC10.html)